product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
USP2 Antibody
catalog :
8036
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, dog
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 1
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:500; loading ...; fig 2b
Wei T, Biskup E, Gjerdrum L, Niazi O, Ødum N, Gniadecki R. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma. Oncotarget. 2016;7:48391-48400 pubmed publisher
product information
SKU :
8036S
Product-Name :
USP2 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk, (Dg, Hr)
Applications :
Western blot
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
68
Host :
Rabbit
Target :
USP2
Primary-Protein :
USP2
Alt-Names :
41 kDa ubiquitin-specific protease,Deubiquitinating enzyme 2,UBP2,UBP41,USP2,USP9,Ubiquitin carboxyl-terminal hydrolase 2,Ubiquitin thioesterase 2,Ubiquitin-specific-processing protease 2,ubiquitin specific peptidase 2,ubiquitin specific protease 12,ubiquitin specific protease 2,ubiquitin specific protease 9
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.